Medicare Enrolled
Dr. V Pourzand, M.D.
Optician · Glendale, CA
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Pourzand from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Pourzand?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Pourzand
Dr. V Pourzand is an optician specialist in Glendale, CA, with 19 years of NPI registration. Based on federal Medicare data, Dr. Pourzand performed 2,927 Medicare services across 2,287 unique beneficiaries.
Between the years covered by Open Payments, Dr. Pourzand received a total of $12,602 from 47 pharmaceutical and/or device companies across 436 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in optician. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Pourzand is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 19 years in practice
▲ Top 28% volume in CA
$12,602 industry payments
Medicare Practice Summary
Medicare Utilization ↗2,927
Medicare services
Top 28% in CA for optician
2,287
Unique beneficiaries
$86
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~154 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Urinalysis, manual A manual laboratory examination of a urine sample to check for various substances and cells. |
729 | $3 | $30 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
482 | $107 | $250 |
| Transvaginal pelvic ultrasound An ultrasound exam using a probe inserted into the vagina to image the uterus, ovaries, fallopian tubes, cervix, and surrounding pelvic structures. |
391 | $110 | $300 |
| Pap smear screening test A screening test to collect and prepare a cervical or vaginal sample for laboratory analysis. |
194 | $49 | $105 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
178 | $69 | $200 |
| Pelvic and clinical breast exam for cancer screening A physical examination of the pelvis and breasts to screen for cervical or vaginal cancer. This procedure involves a clinical assessment performed by a healthcare provider. |
162 | $43 | $85 |
| Abdominal device insertion with pressure and urine flow study A procedure involving the placement of a device into the abdomen, accompanied by a study to measure pressure and urine flow rate. |
138 | $178 | $250 |
| Lactated Ringer's infusion, up to 1000 cc Intravenous administration of Lactated Ringer's solution, a fluid used to replace fluids and electrolytes, in amounts up to 1000 cubic centimeters. |
133 | $2 | $10 |
| New patient office visit (30-44 min) An initial office visit for a new patient lasting between 30 and 44 minutes. This code is used when the total time spent on the date of the encounter falls within this range. |
116 | $91 | $240 |
| Complex urodynamic pressure flow study A test that measures the pressure of urine flow in the bladder during voiding to evaluate how well the bladder and urethra are functioning. |
104 | $331 | $700 |
| Office visit, established patient (10-19 min) An office visit for an existing patient lasting 10 to 19 minutes. The visit involves medical evaluation and management of the patient's condition. |
87 | $32 | $150 |
| Obesity behavioral counseling, 15 minutes A 15-minute face-to-face session focused on behavioral counseling to help manage obesity. |
55 | $27 | $47 |
| Complex urodynamic pressure measurement A test that measures the pressure of urine flow in the bladder along with urethral and voiding pressures. |
45 | $350 | $700 |
| New patient office visit, 15-29 minutes An initial office visit for a new patient lasting 15 to 29 minutes. This code is used when the total time spent on the date of the encounter meets this duration threshold. |
39 | $61 | $120 |
| Endometrial biopsy or polyp removal A procedure to collect a tissue sample from the uterine lining or remove a polyp using a thin, lighted tube inserted through the cervix. |
26 | $1,186 | $1,930 |
| Endometrial biopsy A procedure to remove a small sample of tissue from the lining of the uterus for examination. |
17 | $87 | $200 |
| Non-needle muscle activity measurement of bladder and bowel openings This procedure measures and records the electrical activity of muscles at the bladder and bowel openings without using needles. |
16 | $32 | $450 |
| Electronic assessment of bladder emptying A test that uses electronic monitoring to evaluate how well the bladder empties urine. |
15 | $6 | $40 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
4.5% high complexity
14.8% medium
80.6% routine
Industry Payment Transparency
Open Payments through 2024 ↗$12,602
Total received (2018-2024)
Avg $1,800/year across 7 years
Top 12% in CA for optician
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
47
Companies
436
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$8,734 (69.3%)
Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$3,200 (25.4%)
Other
Charitable contributions, space rental, and other categories
$425 (3.4%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$243 (1.9%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$5,111
2023
$1,629
2022
$2,603
2021
$1,735
2020
$439
2019
$561
2018
$524
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
MIMEDX Group, Inc.
$3,200
Daiichi Sankyo Inc.
$494
Sumitomo Pharma America, Inc.
$285
PFIZER INC.
$157
Amgen Inc.
$137
Teva Pharmaceuticals USA, Inc.
$121
Regeneron Healthcare Solutions, Inc.
$119
Kiniksa Pharmaceuticals International, plc
$114
Phathom Pharmaceuticals, Inc.
$111
MAYNE PHARMA COMMERCIAL LLC
$105
Astellas Pharma US Inc
$64
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$41
CooperSurgical, Inc.
$31
Lilly USA, LLC
$28
ABBVIE INC.
$26
Janssen Biotech, Inc.
$25
Exeltis, USA Inc.
$22
MERZ NORTH AMERICA, INC.
$16
GENZYME CORPORATION
$15
Top 3 companies account for 77.9% of 2024 payments
All-time payments by company (2018-2024) ›
MIMEDX Group, Inc.
$3,200
Daiichi Sankyo Inc.
$1,246
PFIZER INC.
$1,042
Astellas Pharma US Inc
$965
Sumitomo Pharma America, Inc.
$668
Myovant Sciences Inc.
$639
AbbVie Inc.
$622
Medtronic, Inc.
$425
ABBVIE INC.
$413
Amgen Inc.
$347
AbbVie, Inc.
$295
MERZ NORTH AMERICA, INC.
$275
MAYNE PHARMA COMMERCIAL LLC
$194
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$178
TherapeuticsMD, Inc.
$158
Boehringer Ingelheim Pharmaceuticals, Inc.
$151
Kiniksa Pharmaceuticals, Ltd.
$149
Evofem Biosciences, Inc.
$144
Teva Pharmaceuticals USA, Inc.
$121
Regeneron Healthcare Solutions, Inc.
$119
Kiniksa Pharmaceuticals International, plc
$114
Phathom Pharmaceuticals, Inc.
$111
MAYNE PHARMA INC.
$111
Lilly USA, LLC
$89
CooperSurgical, Inc.
$82
Bayer HealthCare Pharmaceuticals Inc.
$65
Allergan, Inc.
$62
Allergan Inc.
$51
Lupin Inc.
$51
Amarin Pharma Inc.
$45
Baxter Healthcare
$44
UROVANT SCIENCES INC
$38
GENZYME CORPORATION
$38
Janssen Biotech, Inc.
$38
Ambu Inc.
$30
Bayer Healthcare Pharmaceuticals Inc.
$29
MEDICEM INC.
$28
Edwards Lifesciences Corporation
$28
Kestra Medical Technology Services, Inc.
$25
HeartFlow, Inc.
$25
Organon LLC
$24
Novo Nordisk Inc
$23
Exeltis, USA Inc.
$22
NESTLE HEALTHCARE NUTRITION INC.
$21
Hologic Sales and Service, LLC
$21
Lexicon Pharmaceuticals, Inc.
$20
Mission Pharmacal Company
$15
Top 3 companies account for 43.6% of all-time payments
Associated products mentioned in payments ›
ANNOVERA · Arcalyst · Assure WCD · Austedo XR · CREON · CitraNatal · DILAPAN-S · DUPIXENT · Edwards SAPIEN 3 Ultra Transcatheter Heart Valve · Enbrel · Endosee · FFRct · GEMTESA · IMVEXXY · INJECTAFER · Inpefa · JARDIANCE · Kyleena · LINZESS · LO LOESTRIN FE · Lupron · MOUNJARO · MYCAMINE · MYFEMBREE · MYRBETRIQ · Mara Console · Myrbetriq · NEXPLANON · ORIAHNN · ORILISSA · Orilissa · PAXLOVID · PREMARIN · Paragard T 380A · Phexxi · Repatha · Rybelsus · SEPRAFILM · SLYND · SOLOSEC · SOLOSEC-CEEK · STELARA · THINPREP 2000 PROCESSOR · TRULICITY · VESICARE · VIBERZI · VOQUEZNA · VOWST · VRAYLAR · Vascepa · Veozah · Verquvo · XEOMIN · XIFAXAN · XIFAXANIBSD · XTANDI · Xeomin
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (69%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Geographic Context
Opticians within 10 mi
1,416
Per 100K population
14.4
County median income
$87,760
Nearest hospital
USC VERDUGO HILLS HOSPITAL
1.4 mi
1.4 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Pourzand is a clinical cardiology specialist, with above-average Medicare volume (top 28% in CA), with low-engagement industry engagement in the top 12% of CA peers, with 19 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Pourzand experienced with urinalysis, manual?
Based on Medicare claims data, Dr. Pourzand performed 729 urinalysis, manual services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Pourzand receive payments from pharmaceutical companies?
Yes. Dr. Pourzand received a total of $12,602 from 47 companies across 436 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Pourzand's costs compare to other opticians in Glendale?
Dr. Pourzand's average Medicare payment per service is $86. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Pourzand) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Opticians in Glendale
Browse opticians in Glendale ranked by procedure volume and transparency data.
Highest volume
Top Opticians in CA
Opticians ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Opticians in CA
Which CA opticians receive the most from drug and device companies.
By company
MIMEDX Group, Inc. Payments to Doctors
See all physicians who received payments from MIMEDX Group, Inc.
By company
Daiichi Sankyo Inc. Payments to Doctors
See all physicians who received payments from Daiichi Sankyo Inc.
By company
PFIZER INC. Payments to Doctors
See all physicians who received payments from PFIZER INC.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology